Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004766654 | SCV005381592 | pathogenic | Neurofibromatosis, type 1 | 2024-08-02 | criteria provided, single submitter | clinical testing | Variant summary: NF1 c.6309_6310delAC (p.Leu2104GlyfsX3) results in a premature termination codon, predicted to cause absence of the protein due to nonsense mediated decay, which is a commonly known mechanism for disease. The variant was absent in 250992 control chromosomes (gnomAD). To our knowledge, no occurrence of c.6309_6310delAC in individuals affected with Neurofibromatosis Type 1 and no experimental evidence demonstrating its impact on protein function have been reported. No submitters have cited clinical-significance assessments for this variant to ClinVar. Based on the evidence outlined above, the variant was classified as pathogenic. |